Enable Accessibility Enable Accessibility

Director Share Dealings

September 30, 2014

Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that today Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from July 1 to September 30, 2014.

  Type of Security(1) Number of Shares/ADSs
Dominic Blakemore Shares 98
William Burns Shares 99
Dr. Steven Gillis ADSs 32
Dr. David Ginsburg ADSs 30
David Kappler Shares 104
Susan Kilsby ADSs 100
Anne Minto Shares 104
David Stout ADSs 32

(1) One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at prices of £53.45 per Share and $259.9747 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

 

For further information please contact:

Investor Relations
Jeff Poulton
jpoulton@shire.com
+1 781 482 0945

Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157

Media
Stephanie Fagan
sfagan@shire.com
+1 781 482 0460

Gwen Fisher
gfisher@shire.com
+1 484 595 9836

 

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

www.shire.com

Click here for the PDF version of this press release.